Ram Prasad Sahu

No near-term triggers for building materials as Q2 growth stays muted

Building materials companies logged mid single-digit Q2FY26 growth amid monsoon disruption, weak retail demand. Brokerages remain split on an H2 rebound as pricing, PVC and competition stay in focus

US portfolio, margin expansion to drive gains for pharma major Lupin

Complex generics and better mix fuel recovery cycle

Auto rally doesn't downshift as Q3 outlook stays steady on firm demand

Strong order books keep automakers driving past slowdown fears

Volume pick-up key to more gains for innerwear major Page Industries

Demand has, however, picked up towards the end of the quarter and continued in the post festive period as well

Margin expansion likely to drive earnings upgrades for Tech Mahindra

Antique Stock Broking has maintained a hold rating, given that a sustained improvement in large-deal wins is key to delivering FY27 growth acceleration

Cooling product makers face near-term concerns as recovery hopes fade

Outlook for listed consumer durable majors may stay muted

Indian Hotels Company needs H2 to turn the key and restart the stay

Renovations easing and wedding-heavy months ahead may help close the gap left by a soft start

Max Healthcare builds growth runway with brownfield expansion push

Stock is trading at 52 times its FY27 earnings estimates

Higher demand to help Indian Hotels Company post recovery in H2FY26

After a muted first half, the hotel major expects double-digit RevPar and revenue growth driven by renovations, room additions and peak-season demand

Non-auto segments to drive growth for Bharat Forge as demand recovers

Despite demand challenges and export headwinds, analysts say Bharat Forge's diversified revenue base, strong defence order pipeline

Max Healthcare gears up for expansion-led growth and stronger margins ahead

Max Healthcare posted healthy Q2 performance on strong patient volumes and ARPOB, with brownfield expansion

Rural recovery, exports to drive volume growth for Hero MotoCorp

The stock currently trading 20x its FY27 earnings estimates

Diversified portfolio, higher margins to drive gains for Ashok Leyland

A smarter load mix and tightened cost base give it a cleaner, more controlled run than its biggest rival

Multiple growth triggers strengthen outlook for Samvardhana Motherson

Samvardhana Motherson delivered stronger-than-expected operating performance in Q2, prompting brokerages to raise estimates as higher content per vehicle

IT recovery key for Info Edge as Q2 growth lags on weak hiring trends

Recruitment gains in non-tech, real estate, matrimony cushion impact of weak tech hiring

Fundraise, AGR clarity key for Vodafone Idea's next phase of recovery

Brokerages have mixed views on telco's operational performance

Expensive valuations may limit upside for Divi's Laboratories stock

Despite strong custom synthesis growth and better-than-expected quarterly results, analysts caution that high valuations could restrict near-term gains for Divi's Laboratories

High-growth segments, acquisition to drive gains for Torrent Pharma

Led by the India business and rest-of-the-world markets, the company reported a robust 14.3 per cent year-on-year (Y-o-Y) growth in revenues

Fresh coat of confidence for legacy paintmakers as stocks rebound

Birla Opus' early gloss fades, giving seasoned players room to repaint the market as disruption fears dry out and demand colours back in

Growth momentum, lower leverage to drive gains for agrochemical company UPL

Brokerages bullish on stock amid easing leverage situation